PCM
IONS icon

Peregrine Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-131,630
Closed -$5.27M 343
2024
Q3
$5.27M Sell
131,630
-394
-0.3% -$15.8K 0.16% 209
2024
Q2
$6.29M Buy
132,024
+13,426
+11% +$640K 0.18% 196
2024
Q1
$5.14M Buy
118,598
+10,774
+10% +$467K 0.15% 236
2023
Q4
$5.45M Sell
107,824
-18,569
-15% -$939K 0.16% 218
2023
Q3
$5.73M Sell
126,393
-22,805
-15% -$1.03M 0.17% 223
2023
Q2
$6.12M Sell
149,198
-49
-0% -$2.01K 0.17% 230
2023
Q1
$5.33M Buy
149,247
+17,536
+13% +$627K 0.15% 237
2022
Q4
$4.98M Buy
131,711
+8,315
+7% +$314K 0.16% 234
2022
Q3
$5.46M Sell
123,396
-6,828
-5% -$302K 0.18% 224
2022
Q2
$4.82M Sell
130,224
-96
-0.1% -$3.55K 0.15% 241
2022
Q1
$4.83M Sell
130,320
-9,401
-7% -$348K 0.11% 246
2021
Q4
$4.25M Buy
139,721
+3,934
+3% +$120K 0.09% 251
2021
Q3
$4.55M Sell
135,787
-26,741
-16% -$897K 0.09% 250
2021
Q2
$6.48M Sell
162,528
-9,820
-6% -$392K 0.12% 254
2021
Q1
$7.75M Sell
172,348
-5,956
-3% -$268K 0.14% 247
2020
Q4
$10.1M Buy
178,304
+1,020
+0.6% +$57.7K 0.19% 230
2020
Q3
$8.41M Sell
177,284
-16,746
-9% -$795K 0.22% 152
2020
Q2
$11.4M Sell
194,030
-28,312
-13% -$1.67M 0.33% 118
2020
Q1
$10.5M Buy
222,342
+11,499
+5% +$544K 0.38% 110
2019
Q4
$12.7M Buy
210,843
+16,514
+8% +$998K 0.32% 127
2019
Q3
$11.6M Buy
194,329
+6,768
+4% +$405K 0.32% 128
2019
Q2
$12.1M Sell
187,561
-1,527
-0.8% -$98.1K 0.3% 139
2019
Q1
$15.3M Sell
189,088
-78,404
-29% -$6.36M 0.38% 119
2018
Q4
$14.5M Sell
267,492
-1,890
-0.7% -$102K 0.41% 108
2018
Q3
$13.9M Sell
269,382
-57,383
-18% -$2.96M 0.33% 133
2018
Q2
$13.6M Buy
+326,765
New +$13.6M 0.34% 128